Regular Insulin vs Rapid Insulin Delivered by V-Go
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 136 participants.
Also called NCT03495908
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 136 participants
- Sponsor
- East Coast Institute for Research
- Registry
-
NCT03495908
-
- Other papers using this trial's data
- Efficacy, safety and cost-effectiveness comparison between U-100 human regular insulin and rapid acting insulin when delivered by V-Go wearable insulin delivery device in type 2 diabetes
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT03495908. Randomized; no masking; primary purpose treatment. Start 2018-04-09 (actual); primary completion 2019-08-12 (actual). Results posted on 2021-01-25.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Regular Insulin vs Rapid Insulin Delivered by V-Go
- Condition
- Type 2 Diabetes
- Condition
- Type 2 Diabetes Mellitus
- Intervention (Device)
- VGo
- Lead sponsor
- East Coast Institute for Research
- Collaborator
- Valeritas, Inc.
- Collaborator
- Dallas Diabetes Research
Record details
- Record id
cardio:ct-nct03495908- Content hash
e0551f1377b6cbcfbd69bdf218e919e3c6ccc525db92ccc31e396f189cec2d39